Quantification of miRNA by qRT-PCR

TI Taisuke Imamura
SK Shuhei Komatsu
DI Daisuke Ichikawa
MM Mahito Miyamae
WO Wataru Okajima
TO Takuma Ohashi
JK Jun Kiuchi
KN Keiji Nishibeppu
TK Toshiyuki Kosuga
HK Hirotaka Konishi
AS Atsushi Shiozaki
KO Kazuma Okamoto
HF Hitoshi Fujiwara
EO Eigo Otsuji
request Request a Protocol
ask Ask a question
Favorite

The miRNAs were quantified by qRT-PCR using a Human TaqMan MicroRNA Assay Kit (Applied Biosystems, Foster City, CA). The reverse transcription reaction was performed using a TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems). qPCR was run on a StepOnePlus PCR system (Applied Biosystems), and cycle threshold (Ct) values were calculated with StepOne Software v2.0 (Applied Biosystems).

As previously reported [13], we used an approach for data normalization based on spiking the samples with a synthetic RNA oligonucleotide, cel-miR-39, which does not exist in the human genome. C. elegans cel-miR-39 was purchased as a custom-made RNA oligonucleotide (Qiagen, Valencia, CA). The oligo used for spiking, as a mixture of 25 fmol of oligonucleotide and water in a total volume of 5 µl, was introduced after the addition of 2X Denaturing Solution (Ambion) to the plasma sample to avoid degradation by endogenous plasma RNases. As a control for each RNA sample, cel-miR-39 was used for the TaqMan qRT-PCR assays (Applied Biosystems) as described above. We normalized the data across samples using the 2−ΔΔCt method relative to cel-miR-39. However, the expression of miRNAs from tissue samples and cultured cells was normalized using the 2−ΔΔCt method relative to U6 small nuclear RNA (RNU6B).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A